TOTazro Ohta

Tazro Ohta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tazro Ohta has a total of 413 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Automated Generation and AI-Prioritized Legal Evaluation of 7488 Pharmacist National Examination Items on Pharmacy Law, Institutional Systems, and Ethics: A Development and Feasibility Study (Preprint)

    by Sakiko Oishi, Makoto Hiraide, Takashi Kawaguchi, Masahiro Ogata, Koichi Masuyama, Tazro Ohta, Yusuke Hori, Akiko Hanai

    BACKGROUND Generative artificial intelligence (AI) and large language models (LLMs) are increasingly used for automated item generation in health professions education, but their outputs remain vulnerable to hallucination. This vulnerability is especially consequential in pharmacy law, institutional systems, and ethics, where items must track precisely worded, periodically amended statutes. Previous studies have generated small item sets and, where evaluated, relied on exhaustive expert review, which does not scale to curriculum-wide item banks. OBJECTIVE This study evaluated the feasibility (completion, reproducibility, and expert agreement) of a 2-stage pipeline that generates a curriculum-scale bank of Japanese Pharmacist National Examination–style items and exhaustively screens them with an independent LLM-based legal compliance checker. It also assessed the checker's real-world performance through an AI-prioritized, human-in-the-loop expert review. METHODS In Stage 1, 2 Dify workflows (Gemini 2.5 Flash) generated items across a 500-topic × 3-format × 5-difficulty-level matrix (target 7500). In Stage 2, a locally run 2-round checker (Qwen2.5:32B initial judgment; Llama3.3:70B critical reverification) screened every item against statutes from Japan's e-Gov database and assigned a verdict of compliant, caution, or noncompliant. For evaluation, Stage 3 used Qwen2.5:32B to assign each item a 10-point review-priority score from the checker's output alone, and the 100 highest-priority items were selected; in Stage 4, 2 pharmacy-law faculty members independently rated them on a 0-3 usability scale (agreement assessed by Cohen κ). Post hoc audits identified a text-parsing defect in the checker's verdict-extraction code and an arbitrary file-order tie-break in the prioritization script; verdicts and the top-100 selection were recomputed from preserved outputs without new inference. RESULTS Of 7500 planned items, 7488 were valid. Under corrected verdicts, 6711 were compliant, 601 received a caution verdict, and 176 were noncompliant; the parsing defect had inflated the noncompliant count nearly 3-fold (486 vs 176) and changed 528 verdicts. Practical linked-item sets showed the highest caution rate (11.6% vs 6.3% for Essential and 6.1% for Theoretical). Of the 100 prioritized items, 40 were reclassified as compliant after correction. Because 891 items tied at a score of 8, the file-order tie-break, not the priority score, determined 53 of the 100 items, overrepresenting Essential items (51/100); a seeded random tie-break replaced 50 of the 100 items and eliminated the skew. Faculty agreement on the original set was low (unweighted κ=–0.04; linear-weighted κ=0.09), with a systematic severity difference observed between reviewers. CONCLUSIONS The pipeline generated and exhaustively screened a curriculum-scale item bank, but 2 independent defects in the deterministic code—a verdict-extraction parser and a ranking tie-break—distorted the reported noncompliance rate and expert review allocation. Such code warrants the same evaluation as prompts and retrieval. The faculty review must be repeated on the corrected selection using a calibrated rubric, before operational use. CLINICALTRIAL None

  • Open Access

    The GA4GH Workflow Execution Service: A Standard API for Workflow Execution and Management in Genomics

    by Valentin Schneider-Lunitz, Landfried Kraatz, Patrick Magee, Venkat S. Malladi, Brian D. O’COnnor, Susheel Varma, James Eddy, Hirotaka Suetake, Jeff Gentry, Michael R. Crusoe, et al.

    Motivation: Rapid growth in life science data generation has led to large and increasingly distributed collections of sensitive genomic data. To analyse this data, researchers increasingly rely on computational workflows to enable scalable, portable and reproducible analysis. However, these workflows are executed by specialized workflow engines across heterogeneous compute environments, each with its own requirements. As a result, users often need engine- and compute-environment-specific knowledge to submit, monitor and manage workflow execution, increasing the barriers to interoperability. These challenges are compounded in large-scale projects, where workflow runs must be dispatched to local clusters, cloud platforms or data hosting infrastructures with different underlying technologies. Results: We describe the Global Alliance for Genomics and Health (GA4GH) Workflow Execution Service (WES) API, an approved GA4GH standard first released in 2018, together with its data model and the endpoints that define a unified interface for workflow execution. By standardizing workflow invocation, the WES API allows a single client to submit, monitor and cancel workflow runs across diverse workflow engines and compute backends, such as scheduling clusters or cloud platforms. We surveyed thirteen adoptions of the standard, covering standalone services and platforms in four programming languages. In a two-site demonstration, a WES implementation from Germany and one from Japan executed the same federated allele-frequency analysis with site-specific adjustments and only aggregated results leaving either site, demonstrating that it is possible to run the same analysis across independently built and operated WES services in different countries. From the gaps identified, we propose extensions for community discussion. Availability and implementations: The latest version of the WES API repository can be found at https://github.com/ga4gh/workflow-execution-service-schemas (DOI: https://doi.org/10.59756/m382x-ww ). The full Reference Documentation can be viewed at: https://ga4gh.github.io/workflow-execution-service-schemas/docs/ Contact: valentin.schneider-lunitz@bih-charite.de

  • Open Access

    BioHackrXiv: Hacking for better PDFs

    by Egon Willighagen, Pjotr Prins, Tazro Ohta

    BioHackrXiv continues to host project reports from biohackathon events (Prins et al., 2022).It has published more than 150 preprints and are indexed by Europe PMC and notable preprintsare indexed by Wikidata too. It has supported multiple biohackathons, including the DBCLSBioHackathon and BioHackathon Europe series (Garcia et al., 2020). A full overview ofsupported meetings is available from the index.biohackrxiv.org website. The original Markdownsetup with metadata in YAML headers (Perk et al., 2024) has been extended since 2020 withsupport for citation intent annotations with the Citation Typing Ontology (Willighagen et al.,2023), making ORCID identifiers for authors and ROR identifiers for research organizationsvisible in the PDFs (Willighagen & Ohta, 2025), and support for the Contributor Role Taxonomy(CRediT) annotation of author roles (McNutt et al., 2018). These things have been developedwith the help of the same communities BioHackrXiv supports.

  • Workflow Execution Service (WES)

    by Ga4 Gh, Valentin Schneider-Lunitz, Landfried Kraatz, Patrick Magee, Venkat Malladi, Brian O’COnnor, Susheel Varma, James Eddy, Hirotaka Suetake, Jeff Gentry, et al.

    The WES API is a standard way to run and manage portable workflows.

  • Open Access

    DBCLS BioHackathon 2026 report: An interactive, harmonised BioSample metadata resource for biological sample discovery

    by Shuya Ikeda, Núria Fàbrega, Hirotaka Suetake, Tazro Ohta

    The BioSample database contains tens of millions of records describing biological samples, but their metadata are submitted largely as key--value pairs with inconsistent field names, terminology and free-text descriptions, limiting search and reuse. Before the DBCLS BioHackathon 2026, we used a pipeline based on locally hosted large language models (LLMs) to extract nine types of biological information (cell line, cell type, tissue, disease, drug, knockout gene, knockdown gene, overexpressed gene and ChIP antigen) from 4.2 million human and mouse BioSample records and map them to ontology terms, producing a harmonised collection of 8.2 million extracted values. During the BioHackathon, we extended this work in three directions. First, we developed an alpha version of a web application for searching this collection by ontology terms and visualising the experimental conditions of selected samples. Second, we developed a provenance-tracing procedure, combining deterministic matching with LLM-based checks, that linked 99% of extracted values to supporting text in the original records. The resulting provenance links showed that although 32 submitted field names accounted for 90% of the evidence, the remaining 10% was spread across more than 6,000 other field names. Third, we developed a procedure in which an LLM assesses mapping correctness and classifies the causes of errors, offering a scalable alternative to building new manually curated gold standards. Our preliminary results show the potential of locally hosted LLMs to harmonise existing BioSample metadata at scale. Future work will validate the LLM-based evaluations with human experts and extend the approach to additional species.

  • Open Access

    BioHackrXiv: Creating a federated publishing platform

    by Arun Isaac, Egon Willighagen, Tazro Ohta, Toshiaki Katayama, Pjotr Prins

    The first BioHackrXiv preprint was published in 2020, using a platform based on the idea of using Markdown (Prins et al., 2022), and BioHackrXiv can be considered a preprint success with over 119 publications (per September 2025) with over 30 publication added per year. Machine-readable metadata is added to the Markdown that is added includes the title, keywords, the author names, their affiliations, and details about the Biohackathon event the preprint is related to.

  • Open Access

    A transcription factor regulatory atlas for activity inference and perturbation prediction

    by Hikaru Sugimoto, Koki Tsuyuzaki, Zhaonan Zou, Shinya Oki, Tazro Ohta, Eiryo Kawakami

    Inferring transcription factor (TF) activity from transcriptomes and predicting transcriptome-wide responses to TF perturbations remain challenging, in part because available TF–mRNA resources often face a trade-off between precision and coverage and typically lack signed regulatory information. Here, we present TFActProfiler, a TF–mRNA resource and computational framework that learns signed, quantitative TF–mRNA regulatory coefficients by integrating heterogeneous prior evidence (ChIP-based, motif-based, and curated TF–mRNA annotations) with large-scale bulk and single-cell RNA-seq atlases. TFActProfiler contains 2 606 176 signed TF–mRNA interactions and improves TF activity inference in TF knockdown benchmarks relative to widely used regulon resources while retaining broad TF and target coverage. In addition, because the same learned regulatory coefficients can be used to model downstream transcriptional effects, TFActProfiler enables prediction of transcriptome-wide gene expression responses to TF knockdown without training on task-matched perturbation data. When perturbation datasets are available, TFActProfiler can be further refined to achieve performance comparable to state-of-the-art machine-learning baselines. By providing a direction-aware representation of TF–mRNA regulation for both activity inference and perturbation-response modeling, TFActProfiler supports systematic dissection of gene regulatory programs across diverse cellular contexts.

  • Open Access

    CATaN maps gene regulatory programs that shape genetic risk across complex diseases

    by Haruka Takahashi, Hiroaki Hatano, Michihiro Kono, Koma Haruta, Masahiro Nakano, Reza Bagherzadeh, Maximilian M Drees, Yuki Oguma, Daichi Harita, Tsugumi Kawashima, et al.

    Causal variants of complex traits are enriched at transcription factor (TF) binding sites and are thought to contribute to pathology by disrupting TF activity and thereby causing transcriptome dysregulation. However, existing approaches typically address TF-mediated gene regulatory networks (TF-GRNs) and transcriptomes separately, and methods that jointly leverage both to systematically assess disease heritability remain limited. We aimed to develop a framework that jointly leverages TF-GRNs and transcriptomes to assess disease heritability. Here, we constructed a matrix encoding TF-GRNs and developed an unsupervised analytical pipeline, Canonical correlation Analysis of Transcriptome and TF-gene regulatory Networks (CATaN). CATaN applies canonical correlation analysis (CCA) to extract canonical correlation (CC) components, i.e., shared variation components between transcriptomes and TF-GRNs, and converts them into genome-wide functional annotation scores connected to stratified LD score regression (S-LDSC) for heritability analysis. We applied CATaN to eight datasets, including 19,198 bulk samples and 611,772 single cells from human and mouse sources, identifying 588 CC components that are significantly enriched for SNP heritability across 69 complex traits. Notably, functional annotation tracks based on these TF-GRNs are distinct from transcriptome signatures prioritized by LDSC-SEG, with greater heritability enrichment for a subset of traits. Finally, we suggest that CATaN may help prioritize candidate causal variants for experimental fine-mapping using genome editing. Together, integrating TF-GRNs with transcriptomes reveals disease-relevant regulatory programs that are not fully captured by transcriptome-based analyses alone.

  • Open Access

    ChIP-Atlas 2025 update: 10-year anniversary of a data-mining platform for exploring epigenomic landscape

    by Zhaonan Zou, Tazro Ohta, Takeya Kasukawa, Shinya Oki

    ChIP-Atlas (https://chip-atlas.org/) is a data-mining platform that systematically processes and integrates public epigenomic profiling data, including ChIP-seq, ATAC-seq, DNase-seq, and Bisulfite-seq, together with curated sample metadata, currently encompassing >460 000 experiments across multiple model organisms. In this 2025 update, an experiment-level quality control framework was embedded in every experiment page, enabling intuitive assessment of data reliability and representativeness. In addition, a parametric analysis of gene set enrichment-based module was implemented, allowing enrichment analysis directly from continuous RNA-seq count tables without relying on threshold-defined, discrete gene lists, thereby helping elucidate underlying gene regulatory mechanisms. Combined with sustained data expansion, these updates advance ChIP-Atlas into a more quantitative and flexible platform for exploring the epigenomic landscape in multicellular organisms, marking its 10th anniversary.


  • Open Access

    Unlocking the potential of Asian genomic data: a collaborative framework for precision medicine innovation

    by Wasin Poncheewin, Naravut Suvannang, Tazro Ohta, Shih Wee Seow, Yuko Kitano, Afiahayati, Yosuke Kawai, Toshiaki Katayama, Mayumi Kamada, Waritta Sawaengdee, et al.

    Asian genomic datasets possess unparalleled potential to advance global understanding of human genetic diversity. Encompassing the world’s largest population pool with diverse ethnicities, these datasets capture comprehensive genomic variations shaped by heterogeneous socioeconomic conditions, climate exposures, and clinical environments. However, current national genome initiatives across Asia demonstrate substantial disunity, stemming from limited cross-border communication and collaborative infrastructure, thereby diminishing their collective impact on biomedical research and precision medicine development. The MedHackathon Asia 2025 catalyzed crucial dialogues toward establishing a regional community dedicated to three pillars: harmonized biobank collaboration, standardized genomic data protocols, and cooperative governance frameworks. This multidisciplinary convening brought together researchers, clinicians, bioinformaticians, and national precision medicine program leaders from across Asia to share best practices, identify implementation challenges, and formulate foundational strategies for sustained cooperation. This community review synthesizes critical outcomes from these deliberations, emphasizing the imperative for continuous regional collaboration while advocating for the development of sustainable architectures enabling: (1) equitable biobank resource sharing, (2) genomic data standardization, and (3) ethical governance models. Through consolidation and expansion of this emerging network, Asian nations are expected to lead transformative contributions to global genomic science while ensuring appropriate representation in biomedical innovation. Such coordinated efforts promise to accelerate healthcare advancements with equitable benefits extending throughout the region and worldwide.